Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies

scientific article

Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043907864
P356DOI10.1186/S13041-015-0154-6
P932PMC publication ID4604618
P698PubMed publication ID26462472
P5875ResearchGate publication ID283237006

P2093author name stringMartin Stangel
Kurt-Wolfram Sühs
Refik Pul
Thomas Skripuletz
Kirsten Müller-Vahl
Philipp Schwenkenbecher
Sascha Alvermann
P2860cites workCaspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channelsQ22011028
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotoniaQ24623766
Connecting the CNTNAP2 Networks with Neurodevelopmental DisordersQ28086930
Pathogenetic role of autoantibodies in neurological diseasesQ28138484
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS diseaseQ28579383
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyQ33551430
Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunctionQ33924303
Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndromeQ34191070
CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorderQ34206301
Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changesQ34312538
Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional studyQ34565885
Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome.Q34613441
Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndromeQ34923513
Immunopathogenic mechanisms in tourette syndrome: A critical reviewQ34974740
Prevalence and sociodemographic correlates of antinuclear antibodies in the United StatesQ35899088
Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndromeQ36536119
Pathogenic and physiological autoantibodies in the central nervous systemQ38020957
Oligoclonal bands in cerebrospinal fluid in patients with Tourette's syndromeQ38339949
Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndromeQ40436503
Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndromeQ42504305
Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodiesQ46189503
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohortQ48297494
Seroprevalence of autoantibodies against brain antigens in health and diseaseQ48774317
Prevalence and clinical correlates of tic disorders in a community sample of school-age children.Q50997227
P433issue1
P921main subjectTourette syndromeQ191779
P304page(s)62
P577publication date2015-10-13
P1433published inMolecular BrainQ6895938
P1476titleGilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies
P478volume8

Reverse relations

cites work (P2860)
Q89879264Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection-Characteristics and Diagnostic Criteria of PANDAS Recognition
Q92106211Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study
Q90379777Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis

Search more.